PE(18:0/18:2)-H
|
Basic information |
| Metabolite name | PE(18:0/18:2)-H |
 | N/A |
 |
C00350 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | PE(18:0/18:2)-H |
| N/A |
|
C00350 |
|
N/A |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between PE(18:0/18:2)-H and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M673 | Type1 | CUS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M673 | Type2 | CUS + fluoxetine group vs. CUS group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M673 | Type2 | CUS + fluoxetine group vs. CUS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M771 | Type1 | CSDS group vs. control group | Colon | C57BL/6J mouse | Up |